Highly-Cited Articles on The Lancet
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) (Cited 7004 time(s))
1998; Lancet; - MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: A randomised placebo-controlled trial (Cited 3629 time(s))
2002; Lancet; - Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial (Cited 3066 time(s))
1998; Lancet; - Assessment of coma and impaired consciousness. A practical scale. (Cited 2774 time(s))
1974; Lancet; - A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) (Cited 2624 time(s))
1996; Lancet; - Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2 (Cited 2401 time(s))
1988; Lancet; - Tamoxifen for early breast cancer: An overview of the randomised trials (Cited 2318 time(s))
1998; Lancet; - Peginterferon alfa-2b plus ribavirin compared with interferonalfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial (Cited 2476 time(s))
2001; Lancet; - Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) (Cited 2386 time(s))
1998; Lancet; - Statistical methods for assessing agreement between two methods of clinical measurement (Cited 12901 time(s))
1986; Lancet; - Access all results for your search in Scopus
Content provided by ![\"scopus\"](\"http://syndic8.scopus.com/images/logo_scopus_small.gif\"){kind=logo}